From the Wires
Market Research Report -- Orphan Drugs Market Fueled by Government Incentives, Commercial Opportunities
By: Marketwired .
Jan. 2, 2013 03:08 AM
ROCKVILLE, MD -- (Marketwire) -- 01/02/13 -- MarketResearch.com has announced the addition of the market research report "Orphan Drugs: Market Environment Products and Companies" to their product offering.
The combination of government incentives to develop drugs for rare diseases and the promise of commercial opportunity will continue to fuel the industry's interest in orphan drugs; and provide hope to patients with debilitating conditions and high unmet medical needs. In addition, the fast track approval system allows companies to enter the market faster and more cost-effectively with the potential to extend indications.
While orphan diseases are rare, patients with rare diseases are numerous. There are up to 7,000 identifiable rare diseases, affecting an estimated 622 million people around the world. There is a clear need to provide rare disease patients with the same quality of care as other patients, and governments have provided incentives to companies developing orphan drugs to address a significant public health need. As effective diagnostics play a greater role in accurately diagnosing orphan diseases, the addressable patient population will expand.
One of the biggest challenges for rare disease patients is obtaining the correct diagnosis, which can be extremely difficult and can take years, or even decades. An increasing number of companies developing drugs for rare diseases are working with diagnostic companies, or their own diagnostic divisions, to establish biomarkers and develop companion diagnostics for patient selection. Companion diagnostics can assist with identifying patients for clinical trials of a novel drug, and may be approved simultaneously as part of a conditional drug approval.
For more information, visit http://www.marketresearch.com/land/product.asp?productid=7283042&progid=85054
About Espicom Healthcare Intelligence
For over 15 years, Espicom has been the choice of senior personnel in industry, commerce and government for high quality, reliable and affordable business intelligence. Espicom serves the Telecommunication, Pharmaceutical, and Medical Device industries supplying, in all, more than 7,500 customers in 50 countries worldwide. Espicom is a full service information provider whose portfolio of products range from single company and market profiles to multi-access global deals for Intranets. Whatever your requirement or budget, Espicom has the information solution you need.
MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Cindy Frei at 240.747.3014 or visit http://www.marketresearch.com.
Latest AJAXWorld RIA Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week